ClinicalTrials.Veeva

Menu

Continuous Glucose Monitoring and Inflammation in Nondiabetic and Diabetic Patients Undergone Hemodialysis

U

University of Pavia

Status

Completed

Conditions

Diabetes
End Stage Renal Disease

Treatments

Device: Continuous Glucose Monitoring (CGM)

Study type

Observational

Funder types

Other

Identifiers

NCT01049152
20090003173

Details and patient eligibility

About

Evaluation of different glycemic variations between the dialysis period and non-dialysis period in two groups: nondiabetic and diabetic patients undergone two different hemodialysis methods. Thirty-six patients, males and females, aged 50-80 years, with end stage renal disease (ESRD) will undergo hemodialysis and continuous glucose monitoring (CGM). The investigators will evaluate also inflammation markers before and after the different hemodialysis methods.

Enrollment

36 patients

Sex

All

Ages

50 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients with or without diabetes mellitus
  • ESRD
  • undergone hemodialysis
  • males and females aged 50-80

Exclusion criteria

  • tumors
  • chronic inflammation diseases
  • AMI
  • acute pulmonary diseases

Trial design

36 participants in 2 patient groups

nondiabetic patients
Description:
nondiabetic patients with ESRD undergone hemodialysis
Treatment:
Device: Continuous Glucose Monitoring (CGM)
diabetic patients
Description:
diabetic patients with ESRD undergone hemodialysis
Treatment:
Device: Continuous Glucose Monitoring (CGM)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems